News | August 07, 2014

Transluminal Technologies Receives CE Mark Approval for Velox CD Vascular Closure Device

Transluminal Technologies LLC CE mark velox CD Vascular Closure Device

August 7, 2014 — Transluminal Technologies LLC, a Syracuse, NY-based medical device company, received CE mark approval for the velox CD Vascular Closure Device. Velox CD provides a safe and predictable means for achieving immediate hemostasis following percutaneous femoral procedures. The single size velox CD is indicated for closing arteriotomies broadly ranging in size from 5 French to 8 French.

Velox CD utilizes patented mechanisms to provide an easy-to-use, single-use instrument to deliver an implant to the vessel wall, thereby avoiding the need for time-consuming manual compression and allowing for shorter patient time-to-ambulation. The implant is wholly made from a proprietary magnesium alloy designed to bioabsorb rapidly after implantation. The implant's intraluminal portion dissolves within 24 hours, while the remainder is completely resorbed within two weeks.

CE mark approval has been granted on the strength of a pivotal clinical trial in which the safety and effectiveness of the device in fully anti-coagulated patients was demonstrated.

Shing-Chiu Wong, director of cardiac catheterization laboratories at the New York Presbyterian — Weill Cornell Medical Center and a leading clinical participant in the velox CD clinical studies stated, "Velox CD is the world's first metal-based bioabsorbable closure device that is simple to use and highly predictable for femoral access site hemostasis. This innovation should prove to be a significant enhancement to the existing offerings."

For more information: www.transluminal.net

Related Content

Vascular Solutions, Teleflex
Feature | December 07, 2016
December 7, 2016 — Teleflex Inc. and Vascular Solutions Inc.
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
Vivasure Medical, Closure Device, Series C financing
News | Vascular Closure Devices| September 12, 2016
September 12, 2016 — Vivasure Medical announced last week that the company has completed a Series C financing of €16.
Rex medical, Closer Vascular Sealing System, VSS, vascular closure, bioresorbable vascular closure device

A close up view of the Rex Medical Closer Vascular Sealing System components.

Technology | Vascular Closure Devices| August 03, 2016
August 3, 2016 — The U.S.
Vivasure Medical, PerQSeal, vascular closure device, CE Mark
News | Vascular Closure Devices| January 18, 2016
Vivasure Medical announced Conformité Européenne (CE) Mark approval of the world’s first fully bioabsorbable...
News | Vascular Closure Devices| December 16, 2015
Scientists at CBSET have presented preclinical evidence that the Manta Large Bore Vascular Closure Device (VCD) from...
Technology | November 06, 2014
Cardinal Health announced that its MynxGrip Vascular Closure Device recently received U.S. Food and Drug Administration...
Videos | Vascular Closure Devices| September 26, 2014
Doug Drachman, M.D., Mass General Hospital Institute of Heart, Vascular and Stroke Care, explains how to prevent and
Feature | September 17, 2014
September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual...
Cardiva Medical Inc. Vascade Vascular Closure System Series 3 financing U.S.
News | August 21, 2014
Cardiva Medical Inc. said it closed the first two tranches of a $16.5 million Series 3 private equity financing and a $...
Overlay Init